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Abstract
Background: Protein biomarkers will play a pivotal role in the future of personalized medicine for both diagnosis
and treatment decision-making. While the results of several pre-clinical and small-scale clinical studies have
demonstrated the value of protein biomarkers, there have been significant challenges to translating these findings
into routine clinical care. Challenges to the use of protein biomarkers include inter-sample variability introduced by
differences in post-collection handling and ex vivo degradation of proteins and protein modifications.
Results: In this report, we re-create laboratory and clinical scenarios for sample collection and test the utility of a
new tissue stabilization technique in preserving proteins and protein modifications. In the laboratory setting, tissue
stabilization with the Denator Stabilizor T1 resulted in a significantly higher yield of phospho-protein when
compared to standard snap freeze preservation. Furthermore, in a clinical scenario, tissue stabilization at collection
resulted in a higher yield of total phospho-protein, total phospho-tyrosine, pErkT202/Y204 and pAktS473 when
compared to standard methods. Tissue stabilization did not have a significant effect on other post-translational
modifications such as acetylation and glycosylation, which are more stable ex-vivo. Tissue stabilization did decrease
total RNA quantity and quality.
Conclusion: Stabilization at the time of collection offers the potential to better preserve tissue protein and protein
modification levels, as well as reduce the variability related to tissue processing delays that are often associated
with clinical samples.
Background
Recent advances in proteomic technologies have spurred
a number of reports examining distinct alterations in
protein expression [1,2] or modification [3-6] that are
associated with, or can classify, disease states in human
patients. Although these biomarker studies provide
important analytical and diagnostic tools, a challenge for
translational research is the transition of findings from
the controlled laboratory environment to the clinical
setting, where variation in tissue acquisition and hand-
ling practices can introduce significant data variability.
This variation can confound data analysis and interpre-
tation, and in turn, impact patient diagnosis and prog-
nosis [7]. Combined with clinical heterogeneity resulting
from genetic, physiological, and environmental factors,
which are typically controlled for in animal models
implemented in the laboratory setting, technical variance
introduced during tissue collection in the clinical
research setting reduces the statistical and classification
power of translational studies. This is especially true
regarding measurements of protein abundance and
modification (e.g. phosphorylation). Standardization pro-
cedures have been proposed for plasma and serum col-
lection in biomarker studies [8] and technologies for
sample preservation of plasma and serum have been
developed [9]. While no standards currently exist for tis-
sue collection, technical approaches to preserve proteins
and reduce technical variance have been proposed [10].
Whether in the laboratory or clinical setting, varia-
tions in tissue retrieval and processing, and any delay in
sample stabilization (e.g., cryopreservation, fixation) can
dramatically alter the quantitative characteristics of the
tissue proteome. As tissue protein biomarkers seek to
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real obstacle is standardizing tissue sample collection
and processing in and around the operating suite, where
most clinical samples are obtained. Total protein
amounts and post-translational modifications are rapidly
impacted by post-collection enzymatic activity. For
example, ex vivo protease and phosphatase activity is
retained but does not reflect true physiological condi-
tions. Artifacts resulting from this residual activity not
only increase inter-sample variability but also contribute
to quantitation inaccuracies, particularly in measures of
dynamic modification states of a given protein (e.g.,
phosphorylation) [11-13]. Traditional approaches to pre-
serving tissues, including freezing and chemical fixation,
require the availability of dry ice and chemicals in the
operating suite. In the clinical environment, the primary
focus of the surgical team is on the patient. In this set-
ting, several hours may elapse from the time of tissue
collection to preservation, depending on the time of col-
lection and the availability of personnel [7].
A recent report by Svensson et al. demonstrates the suc-
cess of rapid tissue stabilizati o ni ni m p r o v i n gp r o t e o m i c
analyses. Using an approach combining heat and pressure
inactivation of enzymes ex vivo, samples can be rapidly
stabilized (< 1 minute) to prevent protein degradation and
loss of post-translational modifications in tissue samples
[10]. This technique does not utilize dry ice or chemicals
and reduces sample complexity by preventing the forma-
tion of abundant protein degradation fragments and main-
tains modified species for up to two hours at room
temperature. More recently, several papers have high-
lighted this technique for proteomic and peptidomic stabi-
lization [14-17]. In this report, we seek to address
unanswered questions related to this technique such as:
1) the stabilization of nucleic acid in combination with the
tissue proteome, 2) an analysis of the entire phospho-
proteome in addition to specific phospho-proteins such as
Erk and Akt, 3) a detailed analysis of multiple clinical sce-
narios including a two hour room-temperature and two
hour 4°C incubation, and 4) an analysis of non-phosphory-
lation protein modification such as glycosylation. The
adoption of this preservation technique in clinical tissue
sample collection has the potential to mitigate the deleter-
ious effects of unavoidable delays in sample preservation,
which would allow for improved biomarker screening.
The purpose of the present study was to determine
whether this commercially available method of rapid tissue
stabilization increases phospho-protein stability and
improves quantitation in tissue samples reflecting labora-
tory and clinically-relevant scenarios of sample collection.
Results
In order to capture the different potential laboratory and
clinical scenarios, we organized animals into groups as
depicted in Figure 1A. For the laboratory setting, follow-
ing tissue dissection, samples were: 1) snap frozen
immediately for storage at -80°C, 2) stabilized immedi-
ately prior to storage at -80°C, or 3) snap frozen imme-
diately prior to storage at -80°C and stabilized after
removal from storage (Figure 1A). To reflect the broader
array of clinically-relevant tissue handling scenarios,
liver samples were dissected into six pieces as follows:
1) maintained at room temperature for two hours, and
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Figure 1 Tissue treatment groups and stabilization procedure.
(A) Brain and lung samples were prepared according to three
scenarios typical of the laboratory setting (n = 6/scenario). For liver
samples the preparations were expanded to six different conditions
potentially encountered in the clinical setting/operating room (n =
6/scenario). (B) Dissected tissue is placed in a hinged Maintainor
cassette. The tissue is placed on the flexible Teflon window in the
center of the cassette and the cassette is closed. Once placed in the
Stabilizer T1 instrument, the air is removed from the cassette by
vacuum and subjected to uniform heat and pressure, as described
in the Methods.
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Page 2 of 13stored at -80°C; 2) stabilized immediately, maintained at
room temperature for two hours, and stored at -80°C; 3)
maintained at 4°C for two hours, and stored at -80°C; 4)
stabilized immediately, maintained at 4°C for two hours,
and stored at -80°C; 5) snap frozen immediately ("best-
case scenario” c o n t r o l )a n ds t o r e da t- 8 0 ° C ;o r6 )s t a b i -
lized immediately, snap frozen, and stored at -80°C
(Figure 1A).
In the “laboratory setting” model, immediate stabiliza-
tion of brain and lung tissue following dissection resulted
in higher phospho-protein levels compared to snap fro-
zen controls. Using automated densitometry methods,
total lane volumes were determined for both the phos-
pho-protein and total protein stains, and ratios of phos-
pho- to total protein were calculated. In lung tissue,
phospho-protein to total protein ratios were significantly
greater in stabilized samples compared to snap frozen
controls and snap frozen then stabilized samples (1.13 ±
0.03 vs. 1.0 ± 0.03 and 0.98 ± 0.03 respectively, p = 0.011,
n = 6/group) (Figure 2A). No statistically significant dif-
ference was observed between snap frozen controls and
snap frozen then stabilized samples (data not shown). In
brain, the average ratio of phospho-protein to total pro-
tein was significantly greater in stabilized samples com-
pared to snap frozen controls and snap frozen then
stabilized samples (1.31 ± 0.05 vs. 1.0 ± 0.03 and 1.0 ±
0.04, respectively; p < 0.001, n = 6/group) (Figure 2C).
Once again, no statistically significant difference was
observed between snap frozen controls and snap frozen
then stabilized samples (data not shown). These data
demonstrate that significantly higher levels of total phos-
phorylated proteins are detected in stabilized samples
isolated from both brain (Figure 2C) and lung
(Figure 2A) than in snap frozen tissue samples. This is
true for both small and large molecular weight phospho-
proteins. Graph insets illustrate the average phospho-
protein to total protein ratios scaled to the respective
control means. To further analyze the phospho-protein
levels, pAktS473 was examined by immunoblotting in
both the lung and brain. While higher pAktS473/total
Akt ratios were observed in stabilized tissue versus snap
frozen controls, this difference did not reach statistical
significance (Figures 2B and 2D respectively).
Although the laboratory setting provides a well con-
trolled environment for tissue collection, the clinical set-
ting is a more challenging venue. To create an accurate
recapitulation of the clinical setting, we first determined
typical tissue collection times in the clinic. In our
research hospital setting, laboratory staff (CBR) acted to
transport liver tissue resected from patients directly
from the OR to pathology for initial processing, and
then to the laboratory for cryopreservation as part of an
IRB approved protocol. The average time from tissue
collection to cryopreservation, with staff immediately
available for tissue transport in the OR at the time of
initial retrieval, was 66 ± 14 minutes (n = 4). Even in
this ideal setting, there is an increased probability that
specific disease biomarkers, especially phospho-proteins,
may be significantly altered, thereby confounding the
analysis and interpretation of any biochemical experi-
ments. To model the clinical environment, “clinical con-
trol” liver samples were left at room temperature or on
wet ice (4°C) for two hours prior to cryopreservation.
These samples were compared to tissue stabilized imme-
diately and left at room temperature for two hours.
Total phospho-protein levels in stabilized samples were
approximately 50% higher than in samples incubated at
room temperature or 4°C (1.5 ± 0.14, Denator, 2 hrs
RT; 1.0 ± 0.08, RT 2 hrs, p < 0.02, n = 3/group) (Figure
3A and 3B).
To more specifically examine preservation of phos-
phorylation, pan phospho-tyrosine levels and specific
phosphorylated proteins were examined. Total phospho-
tyrosine levels were found to be significantly higher in
tissue that was immediately stabilized when compared
to tissue incubated at room temperature (1.4 ± 0.15,
Denator, 2 hrs RT vs. 1.0 ± 0.17, RT 2 hrs; p < 0.05; n =
6/group) (Figure 4A and 4B). Similarly, immediate stabi-
lization followed by two hours at 4°C preserved a signifi-
cantly higher amount of phospho-tyrosine in
comparison to samples incubated at 4°C (1.2 ± 0.15,
Denator, 2 hrs 4°C vs. 0.9 ± 0.13, 4°C 2 hrs; p < 0.05,
n = 6/group). Erk is a major cell signaling protein in the
MAPKinase pathway that is activated by phosphoryla-
tion on threonine 202 and tyrosine 204. Although there
was a marked increase in total phospho-Erk following
stabilization in both room temperature and 4°C paired
groups, the overall effect was not statistically significant
(Figure 4C and 4D).
Akt is a second intracellular signal mediator activated
by the PI3Kinase pathway and is phosphorylated on ser-
ine (S473) residues rather than on tyrosine. To examine
the effects of immediate stabilization on the preservation
of serine/threonine phosphorylation, relative amounts of
phospho-Akt were determined. Immediate stabilization
followed by two hours at room temperature preserved
significantly higher levelso fp A k t S 4 7 3a sc o m p a r e dt o
non-stabilized samples (2.5 ± 0.24, Denator, 2 hrs RT;
1.0 ± 0.36, RT 2 hrs, p < 0.05, n = 5/group) (Figure 5A
and 5B). Similarly, immediate stabilization followed by
two hours at 4°C yielded higher levels of pAktS473 as
compared to non-stabilized samples incubated at 4°C
for two hours alone (2.45 ± 0.30, Denator, 2 hrs 4°C;
1.19 ± 0.15, 4°C 2 hrs, p < 0.005). This indicates that
immediate stabilization preserves phospho-Akt compar-
able to immediate cryopreservation regardless of delays
of 2 hrs at room temperature and 4°C (Figure 5). These
results further demonstrate that integration of rapid
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Figure 2 Preservation of phospho-protein levels in lung and brain samples in laboratory scenarios. SDS-PAGE separated lung (A) and
brain (C) total and phospho-protein levels were determined by SyproRuby (total) and ProQ Diamond (phospho) staining, respectively. In both
tissues stabilization resulted in increased phospho- to total protein levels as compared to snap frozen control samples. Targeted phosphorylation
was examined by immunoblotting using pAktS473 as an example protein. In both the lung (B) and brain (D), pAktS473 to total Akt ratios were
higher in the stabilized tissue samples, but did not reach statistical significance. Data are presented as mean ± S.E.M., n = 6/group (* p < 0.05,
one way ANOVA with SNK).
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Page 4 of 13tissue stabilization in the operating suite can preserve
phospho-protein integrity.
Although immediate stabilization has been shown to
be useful in the preservation of phospho-proteins, little
is known concerning its effects on the preservation of
other protein modifications, such as glycosylation and
acetylation. Interestingly, there was no statistically signif-
icant difference between the amounts of total glycosy-
lated-protein levels in stabilized vs. non-stabilized
tissues (Figure 6A and 6B) (line graph for other four
conditions not shown). No significant differences were
observed in acetylated protein when comparing non-
stabilized and stabilized tissues, with the exception of
tissue that was immediately stabilized then incubated at
4°C when compared to tissue incubated at 4°C only (1.3
± 0.17, Denator, 2 hrs 4°C; 0.89 ± 0.12, 4°C 2 hrs; p <
0.05; n = 6/group) (Figure 6C and 6D).
When examining the effects of immediate stabilization
on RNA, overall RNA purity was found to be compar-
able across all treatment groups within each tissue type
regardless of Denator use (Figure 7A). No significant
difference in total brain RNA quantity was observed if
stabilization preceded immediate cryopreservation. In
lung, immediate cryopreservation prior to stabilization
significantly increased RNA quantity when compared to
samples immediately stabilized followed by cryopreser-
vation (p < 0.05). In liver tissue, stabilization decreased
total RNA quantity when compared to similar samples
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Figure 3 Preservation of phospho-protein levels in liver samples in clinical scenarios. (A) SDS-PAGE separated liver total and phospho-
protein levels were determined by SyproRuby (total) and ProQ Diamond (phospho) staining, respectively. (B) Stabilization, followed by 2 hours at
room temperature prior to cryostorage, resulted in increased phospho- to total protein levels as compared to non-stabilized control samples and
samples stored at 4°C for 2 hours. Data are presented as mean ± S.E.M., n = 3/group (* p < 0.05, un-paired t-test). F - snap frozen; DF - Denator,
snap freeze; FD - snap freeze, Denator; RT - room temperature; DRT - Denator, room temperature 2 hrs; 4°C - wet ice 2 hrs; D4°C - Denator, wet
ice 2 hrs.
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Page 6 of 13incubated at room temperature, 4°C (1401.9 ± 168.13, 2
hrs 4°C vs. 708.2 ± 224.37, Denator, 2 hrs 4°C, p < 0.05,
n = 4/group) and samples immediately snap frozen
without a stabilization step (Figure 7B). Although there
was no significant difference between treatment groups
in terms of RNA quality in lung tissue, brain RNA qual-
ity was significantly higher in the immediate snap freeze
control samples without stabilization compared to the
immediately stabilized samples (7.6 ± 0.37 snap freeze
v s .5 . 9±0 . 5 0D e n a t o r ,f r e e z e ,p<0 . 0 5 ,n=5 - 6 / g r o u p )
(Figure 7C). In liver tissue, immediate stabilization
decreased total RNA quality compared to samples with-
out stabilization treatment (5.4 ± 0.71, 2 hrs RT vs.
2.1 ± 0.10, Denator, 2 hrs RT, p < 0,05, n = 4/group),
4°C (4.6 ± 0.91, 2 hrs 4°C vs. 2.4 ± 0.16, Denator, 2 hrs
4°C, p < 0.05, n = 4/group), and to samples immediately
cryopreserved without the stabilization step (5.1 ± 0.52
snap freeze vs. 2.4 ± 0.2 Denator, freeze, p < 0.005, n =
4/group) (Figure 7C), demonstrating significant degrada-
tion of RNA in all stabilization groups compared to
their paired, non-stabilized controls.
Discussion
Biospecimens have been utilized in pathology research
for more than a century, and currently, many institu-
tional pathology departments comprise the largest sam-
ple repositories [18]. The quality and utility of these
biospecimen collections is often questionable, however,
due to the variations in tissue handling processes, which
may be subject to the same delays as cryopreservation.
Although routine formalin fixation and paraffin embed-
ding procedures preserve the structure and architecture
of specimens, they do not guarantee the preservation of
molecular integrity, which is critical to downstream
analyses.
Because clinical activities necessarily focus on the
patient, samples are often left to be affected by factors
including poor tissue handling, warm ischemia time,
fixation, and storage conditions [7]. It is important to
improve standard protocols for tissue collection. This
includes adequate stabilization that preserves the mole-
cular integrity of the sample, appropriate storage condi-
tions to optimize biospecimen stability, biomolecule
extraction techniques to improve sample quality, and
the active involvement of pathologists in the quality
control of biospecimen collection [19]. In general, stabi-
lization techniques, which do not use chemicals that
may interfere with downstream analyses and which are
simple and quick enough to be routinely used, are
preferred.
Delays in cryopreservation in translational research
include operating suite processing, transport to surgical
pathology, and transport of tissue to the laboratory for
processing. In the ideal setting, where research staff
(CBR) waited in the operating suite to retrieve the sam-
ple directly from the surgical team, personally trans-
ported tissue from the operating suite to pathology, and
then transported the research tissue directly to the
laboratory for cryopreservation, it took more than an
hour. Loss of quality can occur up front, as biospeci-
mens may sit unprocessed for many hours before being
fixed, and more often than not, there is no standard
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the brain regardless of treatment. In lung, when stabilization followed cryopreservation, RNA quantity increased when compared to samples
immediately stabilized followed by cryopreservation (*p < 0.05, Kruskal-Wallis one way ANOVA on Ranks). In liver tissue, stabilization decreased
total RNA quantity when compared to similar samples incubated at room temperature, 4°C, and immediately cryopreserved samples. (C) RNA
quality, determined by relative amounts of degraded vs. intact RNA, was measured by Bioanalyzer and assigned an RNA integrity number (RIN).
RINs range from 10 (intact) to 2 (degraded) with an average RIN being 7. While there were no statistically significant differences seen in lung
tissue, in brain, RNA quality significantly decreased with immediate stabilization prior to cryopreservation compared to immediately
cryopreserved samples. In liver, immediate stabilization significantly decreased RNA quality when compared to similar samples incubated at room
temperature, 4°C, and immediately cryopreserved samples. Data are presented as mean ± S.E.M., n = 5-6/group brain and lung, n = 4/group liver
(* p < 0.05, unpaired t-test). F - snap frozen; DF - Denator, snap freeze; FD - snap freeze, Denator; RT - room temperature; DRT - Denator, room
temperature 2 hrs; 4°C - wet ice 2 hrs; D4°C - Denator, wet ice 2 hrs.
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Page 9 of 13protocol or requirement to document how the tissue is
handled. Without this knowledge, a researcher has no
way of determining whether the results of downstream
molecular experimentation reflect the effects of tissue
handling or the in vivo state. The tissue stabilization
process presented here takes less than 30 seconds and
provides a simple and effective mechanism for rapid sta-
bilization of clinical tissues that more easily preserves
protein biomarkers over alternative preservation meth-
ods such as snap freezing. Additionally, using this
method, stabilized samples can be kept at room tem-
perature for several hours prior to cryopreservation or
tissue analysis without decreases in phospho-protein
content. This provides investigators with a tool that
increases consistency of samples collected in the operat-
ing suite for proteomic analysis. Immediate stabilization
also did not alter the levels of protein modifications
such as glycosylation and acetylation, which are more
resistant to ex-vivo degradation [20,21]. This finding
serves as a negative control, suggesting that stabilization
does not introduce any variability or alter such modifi-
cations, making examination of a wide variety of protein
modifications possible. However, RNA quantity and
quality is significantly reduced as a result of this stabili-
zation technique, indicating a potential limitation for
use when examining the tissue proteome only. By using
the Stabilizor T1 in the operating room or pathology
suite, the clinical team may continue to focus on patient
care and rapidly stabilize a part of biopsy samples to sig-
nificantly decrease phospho-protein degradation.
A number of diagnostic biomarker development efforts
have focused on protein expression [1,2]. Recent studies
have demonstrated that protein modification levels can
be used for diagnostic and prognostic purposes
[3,5,22,6]. Usage of the Stabilizor T1 would potentially
allow for more accurate biochemical diagnostic tests,
especially those designed to monitor phospho-protein
levels. This process requires one piece of instrumenta-
tion, is rapid (< 1 min), and prevents decreases in phos-
pho-protein content with short-term storage at room
temperature. Future studies will test implementation of
this stabilization process in the operating suite to
improve the quality of tissue specimen collection.
Conclusions
Tissue stabilization at collection offers the potential to
more accurately preserve tissue protein and protein
modification levels, such as phosphorylation, and reduce
variability related to tissue processing delays.
Materials and methods
Animals
Three month old male C57BL6/J mice acquired from
Jackson Laboratory (Bar Harbor, ME) were housed four
per cage in solid-bottom cages in the Hershey Center
for Applied Research animal facility, and maintained in
a temperature-controlled environment on a 12/12 hour
light/dark cycle with free access to water and food (Har-
lan Teklad irradiated mouse diet 7912, Madison, WI).
All procedures were conducted in compliance with
Penn State University guidelines for the use of labora-
tory animals and approved by the Institutional Animal
Care and Use Committee.
Tissue Processing
Immediately following sacrifice, brain, lung and liver tis-
sue was rapidly dissected. Brain and lung tissue were
treated in three ways to model the standard controlled
laboratory research setting (n = 6/group): 1) snap frozen
immediately on dry ice prior to storage at -80°C and
processed for biochemical analyses after thawing nor-
mally, 2) stabilized immediately prior to storage at -80°C
and processed after thawing, or 3) snap frozen immedi-
ately on dry ice prior to storage at -80°C and then stabi-
lized after removal from storage and before biochemical
analyses (Figure 1A). Liver samples (n = 6/group) were
dissected into six pieces of roughly equal size that were
treated as follows: 1) snap frozen immediately on dry ice
and stored at -80°C; 2) stabilized immediately, frozen on
dry ice, and stored at -80°C; 3) stabilized immediately,
maintained on wet ice (4°C) for two hours, and stored
at -80°C; 4) stabilized immediately, maintained at room
temperature for two hours, and stored at -80°C; 5)
maintained on wet ice (4°C) for two hours, and stored
at -80°C; or 6) maintained at room temperature for two
hours, and stored at -80°C (Figure 1A).
Tissue Stabilization
Tissue stabilization was conducted using Stabilizor T1
instrumentation (Denator AB, Gothenburg, Sweden).
Tissue samples were placed in inert polycarbonate/ther-
moplastic (Teflon-fluorinated ethylene propylene) Main-
tainor Cards (Denator AB), and air was removed by
automated vacuum to minimize potential protein oxida-
tion and maximize efficient heat transfer. Samples were
then subjected to 5 mbar of pressure and heated to 95°
C for 20 seconds to eliminate residual ex vivo biological
activity (Figure 1B).
Protein isolation and quantitation
Protein was extracted according to Denator AB-
recommended procedures. Using an automated Retsch
TissueLyser II bead mill (Qiagen, Inc., Germantown,
MD) and stainless steel beads pre-chilled on dry ice, fro-
zen tissue samples were homogenized at 15 Hz for one
minute. A volume of 1% SDS, equal to 10 times the
sample mass, was then added to each sample prior to
tissue disruption at 15 Hz for one minute. The
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Page 10 of 13homogenization beads were then removed, and sample
homogenates were incubated at 95°C for 10 minutes
with shaking. During this incubation period, each sam-
ple was briefly sonicated (40 W, two seconds) at five
minute intervals. Soluble protein was recovered by cen-
trifuging tissue homogenates (10,000 × g, 4°C, 10 min-
utes) to pellet insoluble protein. Soluble protein
concentrations were determined by BCA quantitation
assay (Pierce, Rockford, IL).
Total and phospho-protein analysis
Relative abundance of total and phospho-protein was
determined by SDS-PAGE followed by SyproRuby (total)
and ProQ Diamond (phospho) gel staining (Molecular
Probes, Eugene, OR). For brain, lung, and liver samples,
equal protein in equal volumes (30 μgi n1 2μL) was
separated by molecular weight using precast Criterion
Tris-HCl 10.5%-14% acrylamide gradient gels (BioRad,
Hercules, CA). Upon completion of electrophoresis, gels
were fixed in 50% methanol/10% acetic acid and sequen-
tially post-stained first with ProQ Diamond and SyproR-
uby according to manufacturer’s instructions. Briefly,
fixed gels were incubated with ProQ Diamond phospho-
protein stain for 90 minutes at room temperature with
gentle shaking. Following destaining with 20% acetoni-
trile/50 mM sodium acetate (pH 4.0), gels were imaged
with a Typhoon 9410 fluorescent imager (GE Health-
care, Piscataway, NJ) with the following settings: green
laser, 532 nm excitation, 555 nm (20 nm bandpass)
emission. To image total protein abundance, gels were
then co-stained with SyproRuby by overnight incubation
at room temperature with gentle shaking. After destain-
ing with 10% methanol/7% acetic acid, gels were imaged
with the following settings: green laser, 532 nm excita-
tion, 610 nm (30 nm bandpass) emission. Relative abun-
dance of total protein and phospho-protein was
quantitated by automated digital densitometry (1D gel
analysis, ImageQuant TL software; Molecular Dynamics,
Sunnyvale, CA).
Immunoblot Analysis - Liver
To determine the relative abundance of phosphorylated
tyrosine and acetylated lysine, 20 μg of soluble protein
isolated from liver tissue was separated by molecular
weight using precast Criterion Tris-HCl 10.5%-14%
acrylamide gradient gels (BioRad, Hercules, CA) and
transferred to polyvinylidene difluoride (PVDF) mem-
branes (GE Healthcare). Following transfer, membranes
were incubated in 0.1% w/v Ponseau S for five minutes,
rinsed with ddH2O, and then imaged using a reflective
scanner. Membranes were then blocked for one hour in
5% BSA in PBST (PBS and 0.1% Tween). Blots
were incubated overnight at 4°C with primary antibodies
(phospho-tyrosine and acetylated lysine mouse
monoclonal antibodies, Cell Signaling, Danvers, MA)
diluted in blocking solution. After washing with PBST,
each blot was incubated with horseradish peroxidase
(HRP)-conjugated mouse secondary antibody for two
hours at room temperature. Signals were detected with
ECL substrate (ThermoScientific, Rockford, IL), devel-
oped on film, and quantitated using automated digital
densitometry (ImageQuant TL software, GE Healthcare).
To quantitate total and phosphorylated target proteins
in the liver, 40 μg of soluble protein isolated from liver
samples were separated by molecular weight using
NuPage Bis-Tris 4-12% acrylamide precast gels (Invitro-
gen, Carlsbad, CA) and transferred to PVDF membranes
(Invitrogen). After blocking with 5% nonfat milk in TBST
buffer (20 mM Tris-HCl, pH 7.6, 136 mM NaCl, and
0.1% Tween-20) at room temperature (RT) for one hour,
blots were incubated overnight at 4°C with primary anti-
bodies (total Akt, phospho-Akt, total Erk, and phospho-
Erk, all rabbit monoclonal antibodies, Cell Signaling,
Danvers, MA; b-actin mouse monoclonal antibody,
Sigma, St. Louis, MO) diluted in blocking solution. After
washing with TBST, blots were incubated with horserad-
ish peroxidase (HRP)-conjugated species appropriate sec-
ondary antibodies (Amersham Biosciences, Pittsburgh,
PA) for one hour at room temperature. Signals were
detected with ECL substrate (Amersham Pharmacia Bio-
tech, Piscataway, NJ), developed on film and quantitated
using automated digital densitometry.
Immunoblot Analysis - Brain and Lung
To quantitate total and phosphorylated target proteins
in the brain and lung, immunoblotting was performed
as described above, using 30 μg of soluble lung protein
and 15 μg of soluble brain protein.
Total and glyco-protein analysis
Relative abundance of total and glyco-protein was deter-
mined by SDS-PAGE followed by SyproRuby (total) and
ProQ Emerald (glyco) gel staining (Molecular Probes,
Eugene, OR). Equal protein in equal volumes (30 μgi n
12 μL) was separated by molecular weight using precast
Criterion Tris-HCl 10.5%-14% acrylamide gradient gels.
Subsequently, gels were fixed in 50% methanol and 5%
acetic acid in ddH2O for 45 minutes two times with
gentle agitation and then washed twice in 3% glacial
acetic acid for 15 minutes. Following this, gels were
incubated in an oxidizing solution (periodic acid dis-
solved in 3% acetic acid) for 30 minutes, and then
washed three times in 3% glacial acetic acid. Gels were
then placed into a light protected box and incubated
with the ProQ Emerald staining solution for one hour
with gentle agitation and imaged using a UV imager,
EpiChemi Darkroom (UVP Bioimaging Systems, Upland,
CA), at 302 nm. Following imaging, gels were rinsed
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Gels were then washed in 10% methanol and 7% acetic
acid two times for 15 minutes, rinsed twice for five min-
utes in ddH2O, and scanned using a Typhoon 9410
fluorescent imager as described above.
RNA isolation
Total RNA was isolated from each tissue using standard
isolation methods [23-25]. Briefly, each tissue sample
was homogenized in 500 μL cold Tri-Reagent (Sigma-
Aldrich, St. Louis, MO) using an automated Retsch Tis-
sueLyser II bead mill (Qiagen, Inc., Germantown, MD)
and stainless steel beads at 15 Hz for one minute. Sam-
ple volume was brought to 1 mL with additional Tri-
Reagent and 0.1 mL BCP (Molecular Research Center,
Inc., Cincinnati, OH) was added to separate phases.
RNA was precipitated by adding 0.1 mL isopropanol to
the isolated aqueous phase and incubating overnight.
Following precipitation, RNA was purified using Qiagen
RNeasy spin columns (Qiagen, Inc., Valencia, CA) and
resuspended in RNase-free water.
RNA quantitation and analysis
Both quality and quantity were evaluated using the RNA
6000 Nano LabChip with an Agilent 2100 Expert Bioanaly-
zer (Agilent, Palo Alto, CA) and NanoDrop ND100 (Nano-
drop, Wilmington, DE) respectively. RNA integrity
numbers (RINs), as measured by Bioanalyzer, are an accu-
rate measure of RNA degradation with a range from 10
(intact) to 2 (degraded), and were therefore used to demon-
strate RNA quality. Ratios of absorbance at 260 and 280
nm, as measured by Nanodrop, were used to measure RNA
purity. Typically, a ratio of 2.0 is indicative of pure RNA.
Statistical Analysis
All data was scaled to respective control means. Statisti-
cal analyses were performed using two-tailed t-tests, a
one way ANOVA with a Student-Newman-Keuls (SNK)
post hoc analysis, or a Kruskal-Wallis one way ANOVA
for any data that failed normality testing, SigmaStat 3.5
(Systat Software, San Jose, CA).
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